What Medicare covers for Dupuytren's contracture enzyme injection
Medicare Part B covers the enzyme injection collagenase clostridium histolyticum (brand name Xiaflex) for Dupuytren's contracture, but only under specific conditions. The drug itself is covered, and Medicare pays for the injection procedure when a doctor administers it in an office or outpatient setting. However, you will owe a copay — typically 20% of the approved amount after you meet your Part B deductible.
The key limitation is that Medicare requires the contracture to meet certain severity thresholds before the injection is covered. Your doctor must document that the cord (the thickened tissue) is palpable and causing functional impairment — meaning it actually limits your hand movement or ability to use your fingers. Medicare will not cover the injection for mild cases or for contracture that causes no functional loss.
Coverage also depends on whether you have tried other treatments first. Some Medicare Advantage plans (Part C) may have different rules than Original Medicare, so you should contact your specific plan to confirm what it covers before scheduling the procedure.
Key Takeaways
- Medicare Part B covers collagenase injection for Dupuytren's contracture when the contracture causes measurable loss of hand function.
- You pay 20% coinsurance after meeting your Part B deductible, unless you have supplemental coverage.
- Your doctor must document that the cord is palpable and causing functional impairment for the injection to be covered.
- Medicare Advantage plans may have different coverage rules, so contact your plan before scheduling.
- The injection procedure itself is covered when performed in an office or outpatient clinic by a licensed provider.
How Medicare determines whether the injection is medically necessary
Medicare uses a coverage policy that requires your doctor to show the contracture meets two conditions: the cord must be palpable (able to be felt during a physical exam), and it must cause functional impairment. Functional impairment means you cannot fully straighten one or more fingers, or the bent position interferes with daily tasks like gripping, typing, or washing your hands.
Your doctor will document these findings in your medical record before requesting coverage. Medicare's contractor in your state reviews the request and either approves or denies it based on this documentation. If your contracture is mild or causes no loss of function, the request will likely be denied, even if you want the injection.
The contracture must also be in a stage where injection is appropriate. If the disease has progressed to the point where surgery is the only option, Medicare may not cover the injection. Your doctor can advise whether you are at the right stage for this treatment.
What you pay out of pocket
Under Original Medicare Part B, you pay 20% of the Medicare-approved amount for the injection procedure after you have met your annual Part B deductible (which is $240 in 2024, though this amount changes yearly). The actual out-of-pocket cost depends on what your doctor's office charges and what Medicare approves in your area.
If you have a Medigap (supplemental insurance) plan, it may cover some or all of your 20% coinsurance, depending on which plan you have. Plans G, F, and C typically cover the full coinsurance; other plans cover part of it. Check your Medigap policy documents or call your insurer to confirm.
If you have a Medicare Advantage plan, your costs work differently. You may have a copay instead of coinsurance, and the amount depends on your specific plan. Some Advantage plans cover the injection with a small copay; others may not cover it at all. Contact your plan before the procedure to learn your exact cost.
The difference between Original Medicare and Medicare Advantage coverage
Original Medicare Part B covers collagenase injection according to the national coverage policy described above. As long as your doctor documents that the contracture meets the medical necessity criteria, Original Medicare will cover the procedure, and you pay the standard 20% coinsurance.
Medicare Advantage plans (Part C) are run by private insurance companies and can set their own coverage rules, as long as they cover at least what Original Medicare does. Some Advantage plans cover the injection with a copay of $0 to $50; others may require prior authorization or deny coverage altogether. A few plans may also require you to try other treatments (such as hand therapy or steroid injections) before covering collagenase.
If you are in a Medicare Advantage plan and your doctor recommends the collagenase injection, contact your plan's customer service line before scheduling. Ask whether the injection is covered, whether prior authorization is needed, and what your copay will be. This step can prevent unexpected bills or coverage denials.
Prior authorization and what your doctor needs to submit
Most Medicare contractors require prior authorization before the injection is performed. This means your doctor's office must submit documentation to Medicare (or your Advantage plan) for approval before the procedure date. Without prior authorization, the claim may be denied and you could be billed for the full cost.
Your doctor will submit a request that includes your medical history, a description of the contracture (which finger, how severe, how long you have had it), documentation of functional impairment, and proof that the cord is palpable on exam. The request also notes whether you have had previous treatments for Dupuytren's and why the injection is the right next step.
The authorization process usually takes one to two weeks. Your doctor's office will contact you once approval is received, and you can then schedule the injection. If the request is denied, your doctor can appeal with additional information, or you can request a reconsideration. Ask your doctor's office about the appeal process if this happens.
What happens if Medicare denies coverage
If your prior authorization request is denied, you have the right to appeal. Your doctor's office can file an appeal on your behalf, usually within 180 days of the denial. The appeal should include additional clinical information explaining why the injection is medically necessary in your case.
Common reasons for denial include: the contracture does not meet the severity threshold, there is no documented functional impairment, or the medical record does not clearly show the cord is palpable. If your case was denied for one of these reasons, your doctor may be able to gather more detailed exam findings or imaging to support an appeal.
If the appeal is also denied, you can request an independent review by a may have access to independent contractor (QIC), which is a company hired by Medicare to review disputed claims. This process is free and can take 30 to 60 days. You can also contact your State Health Insurance information Program (SHIP) for help understanding your appeal options.
Other treatment options Medicare covers for Dupuytren's contracture
If the collagenase injection is not covered or you choose not to pursue it, Medicare covers other treatments for Dupuytren's contracture. Hand therapy and physical therapy are covered when ordered by your doctor, though you will pay your usual copay or coinsurance for each visit.
Surgical removal of the diseased tissue (fasciectomy or partial fasciectomy) is also covered by Medicare when medically necessary. Surgery is typically considered when the contracture is severe, has progressed despite other treatments, or causes significant functional loss. Like the injection, surgery requires prior authorization and documentation of medical necessity.
Some doctors also offer steroid injections directly into the cord to slow progression, though Medicare coverage for this approach varies by region and plan. Ask your doctor which treatments are options for your specific situation and which ones your insurance covers.
Frequently Asked Questions
Do I need prior authorization before getting the collagenase injection?
Yes, most Medicare contractors require prior authorization. Your doctor's office must submit documentation showing the contracture meets medical necessity criteria before the procedure is scheduled. Without authorization, you may be billed for the full cost. Contact your doctor's office to confirm the authorization process in your area.
Will Medicare cover the injection if I have already tried hand therapy?
Yes. Medicare does not require you to fail hand therapy first, though some Medicare Advantage plans may. If your contracture has worsened despite therapy or if therapy alone is not controlling the disease, the injection can be covered. Your doctor will document the clinical reason why injection is the appropriate next step.
What if my Medicare Advantage plan denies the injection but Original Medicare would cover it?
You can appeal your Advantage plan's denial using the plan's appeal process. If the plan continues to deny coverage, you have the right to disenroll from the Advantage plan and switch to Original Medicare during the annual open enrollment period (October 15 to December 7). Contact your State Health Insurance information Program for help with this decision.
Does Medicare cover the follow-up hand therapy after the injection?
Yes. Medicare covers physical therapy and occupational therapy ordered by your doctor after the injection to help restore hand function and prevent the contracture from returning. You will pay your usual copay or coinsurance for each therapy visit, just as you would for any other covered therapy.
How much will I pay out of pocket for the injection procedure?
Under Original Medicare, you pay 20% of the Medicare-approved amount after meeting your Part B deductible. The exact cost depends on what Medicare approves in your area, which varies. If you have Medigap coverage, it may cover part or all of the 20%. Contact your doctor's billing office for an estimate based on your specific coverage.